| Tumor‐derived exosomes: Implication in angiogenesis and antiangiogenesis cancer therapy C Aslan, S Maralbashi, F Salari, H Kahroba, F Sigaroodi, T Kazemi, ... Journal of cellular physiology 234 (10), 16885-16903, 2019 | 120 | 2019 |
| miR‐142‐3p as tumor suppressor miRNA in the regulation of tumorigenicity, invasion and migration of human breast cancer by targeting Bach‐1 expression B Mansoori, A Mohammadi, M Ghasabi, S Shirjang, R Dehghan, ... Journal of cellular physiology 234 (6), 9816-9825, 2019 | 113 | 2019 |
| Biological effects of IL-21 on different immune cells and its role in autoimmune diseases T Gharibi, J Majidi, T Kazemi, R Dehghanzadeh, M Motallebnezhad, ... Immunobiology 221 (2), 357-367, 2016 | 95 | 2016 |
| Fc-fusion proteins in therapy: an updated view R Jafari, N M Zolbanin, H Rafatpanah, J Majidi, T Kazemi Current medicinal chemistry 24 (12), 1228-1237, 2017 | 88 | 2017 |
| Circulating myeloid‐derived suppressor cells: An independent prognostic factor in patients with breast cancer E Safarzadeh, S Hashemzadeh, PHG Duijf, B Mansoori, V Khaze, ... Journal of cellular physiology 234 (4), 3515-3525, 2019 | 84 | 2019 |
| Gene therapy, early promises, subsequent problems, and recent breakthroughs SR Soofiyani, B Baradaran, F Lotfipour, T Kazemi, L Mohammadnejad Advanced pharmaceutical bulletin 3 (2), 249, 2013 | 84 | 2013 |
| Immunotherapeutic approaches for cancer therapy: an updated review T Kazemi, V Younesi, F Jadidi-Niaragh, M Yousefi Artificial cells, nanomedicine, and biotechnology 44 (3), 769-779, 2016 | 81 | 2016 |
| Prognostic role and clinical significance of tumor-infiltrating lymphocyte (TIL) and programmed death ligand 1 (PD-L1) expression in triple-negative breast cancer (TNBC): a … P Lotfinejad, M Asghari Jafarabadi, M Abdoli Shadbad, T Kazemi, ... Diagnostics 10 (9), 704, 2020 | 80 | 2020 |
| The role of microRNAs regulating the expression of matrix metalloproteinases (MMPs) in breast cancer development, progression, and metastasis M Javadian, T Gharibi, N Shekari, M Abdollahpour‐Alitappeh, ... Journal of Cellular Physiology 234 (5), 5399-5412, 2019 | 58 | 2019 |
| BACH1 silencing by siRNA inhibits migration of HT-29 colon cancer cells through reduction of metastasis-related genes S Davudian, N Shajari, T Kazemi, B Mansoori, S Salehi, A Mohammadi, ... Biomedicine & Pharmacotherapy 84, 191-198, 2016 | 58 | 2016 |
| miR‐142‐3p is a tumor suppressor that inhibits estrogen receptor expression in ER‐positive breast cancer B Mansoori, A Mohammadi, MF Gjerstorff, S Shirjang, Z Asadzadeh, ... Journal of cellular physiology 234 (9), 16043-16053, 2019 | 52 | 2019 |
| Silencing of BACH1 inhibits invasion and migration of prostate cancer cells by altering metastasis-related gene expression N Shajari, S Davudian, T Kazemi, B Mansoori, S Salehi, ... Artificial cells, nanomedicine, and biotechnology 46 (7), 1495-1504, 2018 | 52 | 2018 |
| Parasite-derived microRNAs in plasma as novel promising biomarkers for the early detection of hydatid cyst infection and post-surgery follow-up Z Alizadeh, M Mahami-Oskouei, A Spotin, T Kazemi, E Ahmadpour, P Cai, ... Acta tropica 202, 105255, 2020 | 51 | 2020 |
| microRNA‐193a‐5p inhibits migration of human HT‐29 colon cancer cells via suppression of metastasis pathway N Shirafkan, N Shomali, T Kazemi, D Shanehbandi, M Ghasabi, ... Journal of cellular biochemistry 120 (5), 8775-8783, 2019 | 51 | 2019 |
| Toxoplasmosis and Alzheimer: can Toxoplasma gondii really be introduced as a risk factor in etiology of Alzheimer? M Mahami-Oskouei, F Hamidi, M Talebi, M Farhoudi, AA Taheraghdam, ... Parasitology Research 115, 3169-3174, 2016 | 51 | 2016 |
| Overexpression of HMGA2 in breast cancer promotes cell proliferation, migration, invasion and stemness B Mansoori, PHG Duijf, A Mohammadi, S Najafi, E Roshani, ... Expert Opinion on Therapeutic Targets 24 (3), 255-265, 2020 | 49 | 2020 |
| Update on Fc receptor-like (FCRL) family: new immunoregulatory players in health and diseases D Rostamzadeh, T Kazemi, Z Amirghofran, M Shabani Expert opinion on therapeutic targets 22 (6), 487-502, 2018 | 47 | 2018 |
| The role of V-domain Ig suppressor of T cell activation (VISTA) in cancer therapy: lessons learned and the road ahead N Hosseinkhani, A Derakhshani, MA Shadbad, A Argentiero, V Racanelli, ... Frontiers in Immunology 12, 676181, 2021 | 43 | 2021 |
| Docosahexaenoic acid (DHA) inhibits pro-angiogenic effects of breast cancer cells via down-regulating cellular and exosomal expression of angiogenic genes and microRNAs C Aslan, S Maralbashi, H Kahroba, M Asadi, MS Soltani-Zangbar, ... Life Sciences 258, 118094, 2020 | 41 | 2020 |
| Tumor suppressor microRNAs: Targeted molecules and signaling pathways in breast cancer F Asghari, N Haghnavaz, B Baradaran, M Hemmatzadeh, T Kazemi Biomedicine & Pharmacotherapy 81, 305-317, 2016 | 41 | 2016 |
behzad baradaranImmunology Research Center, Tabriz University of Medical Sciences在 tbzmed.ac.ir 的电子邮件经过验证
